VAXIRA
Vaxira® is an immunotherapeutic agent whose formula consists of the anti-idiotype monoclonal antibody Racotumomab and aluminum hydroxide (HA), a widely used adjuvant. HA improves the production of antibodies, but it is neither immunogenic nor a hapten. It behaves like "depot" at the injection site, from which the antigen is released slowly, and induces the formation of granulomas that attract immunocompetent cells, such as plasma cells that produce antibodies. HA can directly stimulate monocytes to produce proinflammatory cytokines that can activate T cells and possibly stimulate B cell responses.
VAXIRA
Industry:
Biotechnology Therapeutics
Website Url:
http://www.vaxira.com
Status:
Active
Contact:
0800 999 2495
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Font Awesome Apache Google Maps
Official Site Inspections
http://www.vaxira.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
